• 沒有找到結果。

大豆蛋白質對慢性腎衰竭患者血壓、血脂與腎功能的影響

N/A
N/A
Protected

Academic year: 2021

Share "大豆蛋白質對慢性腎衰竭患者血壓、血脂與腎功能的影響"

Copied!
2
0
0

加載中.... (立即查看全文)

全文

(1)

大豆蛋白質對慢性腎衰竭患者血壓、血脂與腎功能的影響

Hyperlipidemic factors contribute to the high cardiovascular risk in hemodialysis patients and may accelerate the progression of renal disease. Soy protein has been shown to reduce some atherogenic lipid concentrations in subjects with normal renal fu nction, and slow progression of renal injury, reduce blood pressure in experimental animals and human subjects. The mechani sm and components of soy responsible have not been fully established. The objectives of this study were to 1) evaluate the eff ect of soy protein on serum lipid profiles and lipoprotein metabolism in hyperlipidemic and normolipidemic hemodialysis pati ents. 2) investigate the effect of the two fractions of soy protein hydrolysate on renal function, blood pressure and lipid metab olism in five-sixths nephrectomized rats, and to examine the active components of soy protein hydrolysate on ameliorating dis ease progression. Hyperlipidemic and normolipidemic hemodialysis patients were enrolled in a randomized, double-blind, pla cebo-controlled clinical trial. Thirty grams of isolated soy protein or milk protein was consumed daily as a beverage at breakfa st or postdialysis for 12 wk. Experimental animals were subjected to a nephrectomy and were fed two fractions isolated from s oy protein hydrolysate prepared by peptic hydrolysis for 13 wk. Results showed soy protein substitution significantly reduced total cholesterol, triglyceride, low-density lipoprotein cholesterol and apolipoprotein B concentrations, and the HDL-cholester ol was significantly increased in hyperlipidemic subjects. There were no significant changes in serum lipid and lipoprotein co ncentrations in normolipidemic subjects. Both soy protein hydrolysate fractions favorably affected chronic renal failure. The s upernatant fraction of soy protein hydrolysate had the most-significant decreases in blood pressure and significantly retarded p rogression of the experimentally induced renal disease. The precipitate fraction of soy protein hydrolysate exhibited significan tly increased fecal excretion of total cholesterol. In conclusion, our findings demonstrate that replacing a part of the daily prot ein with soy protein could be used in the nutritional management of moderately hyperlipidemic hemodialysis patients. The su pernatant fraction of soy protein hydrolysate had most-pronounced effect on slowing the progression of renal disease, and the precipitate fraction of soy protein hydrolysate had a protective effect on renal function resulting from lowering cholesterol.

Key words : soy protein, hemodialysis, hyperlipidemia, soy protein hydrolysate, renal failure, cholesterol, blood pressure

(2)

Effect of soy protein on blood pressure, lipid metabolism and renal function in chronic renal failure

Angiotensin converting enzyme plays a key physiological role in the activation of RAS (renni n-angiotensin system). We investigated the effects of pepsin-digested soy protein hydrolysate (SPH) on blood pressure and ACE activity in three different animal models in this study. In 5/

6-nephrectomized rats, we found soy protein and SPH had the same renoprotective effects and

decrease systolic blood pressure, plasma insulin and renal TNF-a (tumor necrosis factor-a) con

centration. In rats with metabolic syndrome induced by high-fructose-high-fat diet, SPH was a

lso as effective as soy protein in the reduction of blood pressure, plasma glucose and lipids. Th

e soy protein and SPH group also had lower plasma, heart and renal ACE activity and tissue T

NF-a and PAI-1 (plasminogen activator inhibitor-1) level than the control group. However, no

difference in plasma and adipose adiponectin level was found. In the third part of study, we fe

d NO-deficient hypertensive rats diet containing 1%, 3% or 5% SPH. We found that the 5% S

PH group had lower blood pressure, heart and renal ACE activity, renal PAI-1, TNF-a level an

d CYP4A expression than the control group. In pathohistological analysis, we also found that

5% SPH can protective cardiovascular and renal injuries caused by administration of NO synt

hase inhibitor. Furthermore, we isolated the peptides with ACE inhibitory activities in SPH, an

d we found that LKNQRESY, DQMPRRF and LVPPQESQRR were the three most effective

peptides derived from soy protein. Therefore, we suggested that one possible mechanism of th

e beneficial effects of soy protein consumption on hypertension and related tissue injuries may

be the ACE inhibitory peptide derived from digested soy protein.

參考文獻

相關文件

Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis.. Hellen-Bandeira-de-Pontes Santos 1 , Thayana-Karla-Guerra

To evaluate the clinicopathologic features, prognostic factors, and management of patients in the North Chinese population with head and neck squamous cell carcinoma (HNSCC)

Radiomorphometric indices can be used to deter- mine the existence of a porous structure in the man- dible on panoramic images of patients who have scleroderma and may have a high

除了與紅血球作用而代謝成非脂溶性的汞離子 (積於

豆類和奶類 魚、肉 動物性蛋白質、植物性蛋白質 豬油、奶油.

independent of the parametrization.) Because the unit tangent vector has constant length, only changes in direction contribute to the rate of change of T...

SPO has high fatty acids, therefor it has to carry out the acid catalyzed esterification to convert of the fatty acids in SPO to biodiesel first, and then used the

 Promote project learning, mathematical modeling, and problem-based learning to strengthen the ability to integrate and apply knowledge and skills, and make. calculated